The Lemonade Inc Enigma: What’s Causing the Wild Swings in LMND Stock?

TD Cowen has recently initiated Lemonade Inc (LMND) stock to Market Perform rating, as announced on January 10, 2024, according to Finviz. Earlier, on December 1, 2023, Oppenheimer had reduced the stock from a Outperform to Perform. Morgan Stanley also initiated Underweight rating with a price target of $14. Additionally, BMO Capital Markets initiated Underperform […]

Stock Market Sizzler: Lemonade (LMND) Ignites Investor Interest

Lemonade, Inc. (NYSE: LMND) has made waves on the stock market, surging +31.27% or $5.85 to reach $24.60 as of 11:04 AM EDT in Thursday’s trading session. With a trading volume of 4.99 million shares compared to its average volume of 1.21 million, it’s clear that investor interest is spiking. But what’s behind this buzz, […]

Lemonade Inc (LMND) Stock: More Robust Than the Numbers Suggest?

TD Cowen has recently initiated Lemonade Inc (LMND) stock to Market Perform rating, as announced on January 10, 2024, according to Finviz. Earlier, on December 1, 2023, Oppenheimer had reduced the stock from a Outperform to Perform. Morgan Stanley also initiated Underweight rating with a price target of $14. Additionally, BMO Capital Markets initiated Underperform […]

Lemonade Inc (LMND) Posted -52.30% Profit Margin Last Year—Can It Hold Up?

TD Cowen has recently initiated Lemonade Inc (LMND) stock to Market Perform rating, as announced on January 10, 2024, according to Finviz. Earlier, on December 1, 2023, Oppenheimer had reduced the stock from a Outperform to Perform. Morgan Stanley also initiated Underweight rating with a price target of $14. Additionally, BMO Capital Markets initiated Underperform […]

Lemonade Inc (LMND) Stock: Understanding Its Underlying Value

TD Cowen has recently initiated Lemonade Inc (LMND) stock to Market Perform rating, as announced on January 10, 2024, according to Finviz. Earlier, on December 1, 2023, Oppenheimer had reduced the stock from a Outperform to Perform. Morgan Stanley also initiated Underweight rating with a price target of $14. Additionally, BMO Capital Markets initiated Underperform […]

Lemonade Inc (LMND) Stock: Beyond the Surface of Its Performance?

TD Cowen has recently initiated Lemonade Inc (LMND) stock to Market Perform rating, as announced on January 10, 2024, according to Finviz. Earlier, on December 1, 2023, Oppenheimer had reduced the stock from a Outperform to Perform. Morgan Stanley also initiated Underweight rating with a price target of $14. Additionally, BMO Capital Markets initiated Underperform […]

Why Lemonade Inc (LMND) Stock is Currently -1.15% Off from Its 20-Day SMA?

TD Cowen has recently initiated Lemonade Inc (LMND) stock to Market Perform rating, as announced on January 10, 2024, according to Finviz. Earlier, on December 1, 2023, Oppenheimer had reduced the stock from a Outperform to Perform. Morgan Stanley also initiated Underweight rating with a price target of $14. Additionally, BMO Capital Markets initiated Underperform […]

What’s Behind the -6.23% Drop in Lemonade Inc (LMND) Stock? Find Out Now!

TD Cowen has recently initiated Lemonade Inc (LMND) stock to Market Perform rating, as announced on January 10, 2024, according to Finviz. Earlier, on December 1, 2023, Oppenheimer had reduced the stock from a Outperform to Perform. Morgan Stanley also initiated Underweight rating with a price target of $14. Additionally, BMO Capital Markets initiated Underperform […]

Lemonade Inc (LMND) Stock Rated Market Perform by TD Cowen

TD Cowen has recently initiated Lemonade Inc (LMND) stock to Market Perform rating, as announced on January 10, 2024, according to Finviz. Earlier, on December 1, 2023, Oppenheimer had reduced the stock from a Outperform to Perform. Morgan Stanley also initiated Underweight rating with a price target of $14. Additionally, BMO Capital Markets initiated Underperform […]

Why Is Lemonade Inc (LMND) Stock Lagging Behind -9.62% from Its 50-Day SMA?

TD Cowen has recently initiated Lemonade Inc (LMND) stock to Market Perform rating, as announced on January 10, 2024, according to Finviz. Earlier, on December 1, 2023, Oppenheimer had reduced the stock from a Outperform to Perform. Morgan Stanley also initiated Underweight rating with a price target of $14. Additionally, BMO Capital Markets initiated Underperform […]